Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific

Journal of Diabetes

Volumn 5, Issue 3, 2013, Pages 291-299

  Du, Bing ^a   Liu, Shengmao ^a   Cui, Chengji ^b   Wang, Songyan ^c   Cui, Wenpeng ^a  

^a JILIN UNIVERSITY   (China)

^b CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

^c People's Hospital of Jilin Province   (China)

Author keywords

Gene polymorphism; Glucose transporter 1; Meta analysis; Rs841853; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE TRANSPORTER 1;

ARTICLE; CAUCASIAN; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RISK; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

GENE POLYMORPHISM; GLUCOSE TRANSPORTER 1; META-ANALYSIS; RS841853; TYPE 2 DIABETES MELLITUS;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84881554272     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12042     Document Type: Article

References (49)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414: 782-787.
2. Zhang P, Zhang X, Brown J etal. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 293-301.
3. Yu W, Hu C, Jia W. Genetic advances of type 2 diabetes in Chinese populations. J Diabetes. 2012; 4: 213-220.
4. Prokopenko I, McCarthy MI, Lindgren CM. Type 2 diabetes: New genes, new understanding. Trends Genet. 2008; 24: 613-621.
5. ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes. 2003; 52: 568-572.
6. Wilson PW, Meigs JB, Sullivan L etal. Prediction of incident diabetes mellitus in middle-aged adults: The Framingham Offspring Study. Arch Intern Med. 2007; 167: 1068-1074.
7. Hsu CC, Kao WL, Steffes MW etal. Genetic variation of glucose transporter-1 (GLUT1) and albuminuria in 10, 278 European Americans and African Americans: A case control study in the Atherosclerosis Risk in Communities (ARIC) study. BMC Med Genet. 2011; 12: 16-28.
8. Stefanidis I, Kytoudis K, Papathanasiou AA etal. XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy. Dis Markers. 2009; 27: 29-35.
9. Liu Z, Guan T, Chen Z etal. Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int. 1999; 55: 1843-1848.
10. Grzeszczak W, Moczulski DK, Zychma M etal. Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes. Kidney Int. 2001; 59: 631-636.
11. Vijaya Padma V, Anitha S, Santhini E etal. Mitochondrial and nuclear gene mutations in the type 2 diabetes patients of Coimbatore population. Mol Cell Biochem. 2010; 345: 223-229.
12. Li SR, Baroni MG, Oelbaum RS etal. Association of genetic variant of the glucose transporter with non-insulin-dependent diabetes mellitus. Lancet. 1988; 2: 368-370.
13. Makni K, Mnif F, Boudawara M etal. Association of glucose transporter 1 polymorphisms with type 2 diabetes in the Tunisian population. Diabetes Metab Res Rev. 2008; 24: 544-548.
14. Tao T, Tanizawa Y, Matsutani A etal. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: A population association study and molecular scanning in Japanese subjects. Diabetologia. 1995; 38: 942-947.
15. Murakami K, Wilk J, Nishida K etal. Hep-G2 glucose transporter gene polymorphism in Caucasian, Black, Hispanic and Japanese patients with NIDDM. Diabetes Res Clin Pract. 1990; 9: 115-121.
16. Oelbaum RS. Analysis of three glucose transporter genes in a Caucasian population: No associations with non-insulin-dependent diabetes and obesity. Clin Genet. 1992; 42: 260-266.
17. Baroni MG, Oelbaum RS, Pozzilli P etal. Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM). Hum Genet. 1992; 88: 557-561.
18. Alcolado JC, Baroni MG. Restriction fragment length polymorphisms at the GLUT4 and GLUT1 gene loci in type 2 diabetes. Diabet Med. 1992; 9: 58-60.
19. Pontiroli AE, Capra F, Veglia F etal. Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations. Acta Diabetol. 1996; 33: 193-197.
20. Shi Z, Wang S, Liu Z etal. The relationship between GLUT1 gene polymorphism and type 2 diabetes. Guangdong Med J. 2006; 27: 87-88.
21. Lukacs K, Hosszufalusi N, Dinya E etal. The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: A meta-analysis and an individual study. Diabetologia. 2012; 55: 689-693.
22. Cui W, Du B, Zhou W etal. Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: A systematic review and meta-analysis. Mol Biol Rep. 2012; 39: 8551-8558.
23. Hwang CK, Han PV, Zabetian A etal. Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2012; 96: 271-285.
24. Nakao YM, Teramukai S, Tanaka S etal. Effects of renin-angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2012; 96: 68-75.
25. Cui W, Du B, Jia Y etal. Is the C677T polymorphism in methylenetetrahydrofolate reductase gene a risk factor for diabetic nephropathy or diabetes mellitus in a Chinese population? Arch Med Res. 2012; 43: 42-50.
26. Miao RY, Zhao HT, Yang HY etal. Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: A meta-analysis. World J Gastroenterol. 2010; 16: 2931-2942.
27. Zintzaras E, Ioannidis JP. HEGESMA: Genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005; 21: 3672-3673.
28. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539-1558.
29. Kaku K, Matsutani A, Mueckler M etal. Polymorphisms of HepG2/erythrocyte glucose-transporter gene. Linkage relationships and implications for genetic analysis of NIDDM. Diabetes. 1990; 39: 49-56.
30. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984; 33: 176-183.
31. Elbein S, Rotwein P, Permutt MA etal. Lack of association of the polymorphic locus in the 5′-flanking region of the human insulin gene and diabetes in American Blacks. Diabetes. 1985; 34: 433-439.
32. Xiang KS, Cox NJ, Sanz N etal. Insulin-receptor and apolipoprotein genes contribute to development of NIDDM in Chinese Americans. Diabetes. 1989; 38: 17-23.
33. Liu Z, Wang Y, Li L etal. A study on polymorphism of glucose transporter 1 gene in type 2 diabetes mellitus of Guangdong native place. Shanxi Med J. 2007; 36: 776-777. (in Chinese).
34. Liu Z, Guan T, Chen Z etal. Glucose transporter (GLUT1) alleles (XbaI) associated with nephropathy in NIDDM. J Nephrol Dial Transplant. 1997; 6: 305-309.
35. Leucht S, Corves C, Arbter D etal. Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet. 2009; 373: 31-41.
36. Harel Z, Gilbert C, Wald R etal. The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: Systematic review and meta-analysis. BMJ. 2012; 344: e42.
37. Mueckler M, Caruso C, Baldwin SA etal. Sequence and structure of a human glucose transporter. Science. 1985; 229: 941-945.
38. Hruz PW, Mueckler MM. Structural analysis of the GLUT1 facilitative glucose transporter. Mol Membr Biol. 2001; 18: 183-193.
39. Ioannidis JP, Ntzani EE, Trikalinos TA. "Racial" differences in genetic effects for complex diseases. Nat Genet. 2004; 36: 1312-1318.
40. Jorde LB, Wooding SP. Genetic variation, classification and "race". Nat Genet. 2004; 36 (Suppl.): S28-33.
41. Li SR, Oelbaum RS, Bouloux PM etal. Restriction site polymorphisms at the human HepG2 glucose transporter gene locus in Caucasian and West Indian subjects with non-insulin-dependent diabetes mellitus. Hum Hered. 1990; 40: 38-44.
42. Li H, Gan W, Lu L etal. A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes. 2012; 62: 291-298.
43. Qi Q, Hu FB. Genetics of type 2 diabetes in European populations. J Diabetes. 2012; 4: 203-212.
44. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-553.
45. Genuth S, Alberti KG, Bennett P etal. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26: 3160-3167.
46. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997; 20: 1183-1197.
47. Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1985; 727: 1-113.
48. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979; 28: 1039-1057.
49. WHO Expert Committee on Diabetes Mellitus. Second report. World Health Organ Tech Rep Ser. 1980; 646: 1-80.